Data Foundry

Drug recalls 2022

buPROPion Hydrochloride Extended-Release Tablet — Class III drug recall D-0857-2022

Terminated recall by SUN PHARMACEUTICAL INDUSTRIES INC, reported 2022-05-18, distributed nationwide. Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the

Recall numberD-0857-2022
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmSUN PHARMACEUTICAL INDUSTRIES INC, Princeton, NJ, United States
Recall initiated2022-04-29
Classified2022-05-10
Reported by FDA2022-05-18
Terminated2023-09-25
DistributedNationwide (US)
Quantity9,804 bottles
NDC47335-0736, 47335-0736-08, 47335-0736-13, 47335-0736-86, 47335-0736-88, 47335-0737, 47335-0737-08, 47335-0737-13, 47335-0737-86, 47335-0737-88, 47335-0738, 47335-0738-08, 47335-0738-13, 47335-0738-86, 47335-0738-88
Expiration dates2022-10

Product

buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 150 mg packaged in a) 60-count bottle (47335-737-86), b)100-count bottle (47335-737-88), c)500-count bottle (47335-737-13), Rx only Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Halol-Baroda Highway, Halol-389 350, Gujarat, India

Reason for recall

Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister inside the bottle.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0857-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.